$1.78
▼ -1.1% Today
as of Jul 23, 14:20 ET
Last 30 days
Recent Press Releases & News
Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry
Intelligent Bio Solutions Completes Precision Testing of Intelligent Fingerprinting Drug Screening System
Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market
Overview
52-week range
$2.24
$25
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+18.5%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $-1.80 | — | — | -309.1% | +25.5% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-2.82 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.35 | — | — | — | — | financials |
| Fri Aug 15, 2025 | Jun/2025 | $-0.37 | — | — | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.44 | — | — | — | +11.5% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-4.96 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.70 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.43 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-2.07 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-12.48 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Aug 21, 2026 | Jun/2026 | OTHER | — | -$3.70 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $902,138 | $741,134 | $998,415 | — |
| Cost of revenue | $525,421 | $437,035 | $593,506 | — | $387,499 | $384,381 | $525,486 | — |
| Gross profit | $535,381 | $459,739 | $518,291 | — | $341,368 | $223,113 | $346,801 | — |
| Operating income | $-3M | $-3M | $-3M | — | $-3M | $-2M | $-3M | — |
| Net income | $-3M | $-3M | $-3M | — | $-3M | $-2M | $-3M | — |
| EPS (diluted) | $-1.80 | $-2.82 | $-0.35 | — | $-4.41 | $-4.96 | $-0.70 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7M | $740,371 | $2M | $1M | $3M | $2M | $4M | $6M |
| Inventory | $597,469 | $590,246 | $628,177 | $635,215 | $683,488 | $701,280 | $738,789 | $777,537 |
| Total current assets | $10M | $12M | $4M | $4M | $5M | $4M | $6M | $9M |
| Total assets | $15M | $18M | $10M | $8M | $10M | $9M | $12M | $14M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $6M | $7M | $7M | $5M | $5M | $4M | $6M | $6M |
| Total equity | $9M | $11M | $4M | $3M | $5M | $4M | $6M | $8M |
Implied volatility — last 90 days
No IV snapshots yet for INBS.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.